Discovering the function of distinct SWI/SNF complexes
Discovering the function of distinct SWI/SNF complexes
批准号:
EP/X039633/1
负责人:
Gerard Brien
金额:
$164.66万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The SWI/SNF family of complexes are chromatin remodellers, essential for controlling gene expression. Their activities are necessary for normal development and are disrupted in almost 25% of all cancers. Three distinct subclasses of SWI/SNF complex exist in mammals, which have diversified significantly from their evolutionary precursors. However, the reasons for this diversification remain enigmatic; which constitutes the major conceptual gap in our understanding of this essential gene regulatory system. I recently discovered a specific functional role for one of the SWI/SNF subclasses in the paediatric malignancy, synovial sarcoma. Now, I propose that each SWI/SNF subclass has unique/context-dependent functions, which likely have relevance in disease biology. Building on my discovery, within BAFDefiner I am pursuing an ambitious, hypothesis driven program, integrating biochemical, genomic and single-cell analyses to discover the specific functions of the distinct SWI/SNF subclasses.Specifically, my three aims are:(i) To biochemically define the compositions of distinct SWI/SNF subclasses(ii) To discover the unique functions of distinct SWI/SNF subclasses(iii) To define the regulatory roles of SWI/SNF members at single-cell resolutionTo do this, I am developing novel experimental tools using approaches in chemcial biology and single-cell genomics to functionally dissect distinct SWI/SNF subclasses in cells. Implementing these approaches will allow me to derive insights that are well beyond current experimental techniques. Moving our understanding of SWI/SNF complex biology decades into the future; all within the term of this research program. This will close the conceptual gap that currently limits our understanding of SWI/SNF complex diversity, and perhaps most importantly, is an essential step towards devising therapeutic strategies to intervene in cancers (and other diseases) where SWI/SNF function(s) are disrupted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
双硫仑结合并抑制谷氨酸脱氢酶1活性调节Th17/Treg细胞平衡的作用与机制探究
-
批准号:82371755
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王秦兰
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位: